While we did not assess mortality, we did show an increase in COMP proteins in the lungs and bloods of patients with IPF and demonstrated that the increase was associated with decline of FVC over time, concurrent with previous results in other disease and suggesting that COMP should be added to repertoire of proteins evaluated as potential peripheral blood biomarkers in IPF. This evidence concerns the gene COMP and idiopathic pulmonary fibrosis.